Self-emulsifying formulations to increase the oral bioavailability of 4,6,4′-trimethylangelicin as a possible treatment for cystic fibrosis

HIGHLIGHTS

• who: Erica Franceschinis and colleagues from the Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo, Padua, Italy have published the paper: Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4'-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis, in the Journal: Pharmaceutics 2022, 1806 of 11/Nov/2018
• what: For the analysis of the organic solutions of TMA, a volume of 20 µL was injected into the column and a mixture of methanol and water (95:5) was used as mobile phase with a flow rate of 0.8 mL/min.
 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.